LumiThera is a medical device company at the forefront in the development of photobiomodulation (PBM) treatment protocols for patients with ocular diseases and disorders with a focus on dry age-related macular degeneration (AMD).

AMD is an eye disease characterized by damage to the macula – a part of the eye that controls vision. The macula is one component of the retina which is the light-sensitive layer of tissue at the back of the eye that acts as the messenger of visual information to the brain. AMD is the leading cause of blindness in adults over 65. There are two forms of AMD: dry and wet. Approximately 90% of patients with AMD have the dry form and 10% have the wet form. The primary symptom of AMD is visual impairment and irreversible vision loss.

Caution: The Valeda® Light Delivery System is an Investigational Device. Use of Valeda is limited by Federal (or United States) law to investigational use.